Finance

Lists
Why is MREO up 2,16%?
Dive Deeper
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
0,39 USD
+2,16%
(+0,0082) 1D
0,39 USD
+0,52% (+0,0020)
Pre-market
Closed: 5-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
0,37 USD
High
0,40 USD
Low
0,36 USD
Mkt. cap
61,93 млн
Avg. vol.
1,69 млн
Volume
2,58 миң
52-wk high
2,37 USD
52-wk low
0,20 USD
EPS
-0,18 USD
Beta
0,14
Shares outstanding
159,69 млн
No. of employees
39
Open
0,37 USD
High
0,40 USD
Low
0,36 USD
Mkt. cap
61,93 млн
Avg. vol.
1,69 млн
Volume
2,58 миң
52-wk high
2,37 USD
52-wk low
0,20 USD
EPS
-0,18 USD
Beta
0,14
Shares outstanding
159,69 млн
No. of employees
39
News stories
From web sources and news partners
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees39
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to MREO in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current 0,39 USD
3,00 USD (+673,20%)
Average
3,00 USD (+673,20%)
Lowest
3,00 USD (+673,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
3,00 USD
+673,2%
09/17/2026
Priyanka Grover
J.P. Morgan
Sell
Reiterated
-
-
09/15/2026
Kate Dellorusso
LifeSci Capital
Hold
Maintained
-
-
08/15/2026
Gil Blum
Needham
Buy
Maintained
3,00 USD
+673,2%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
1,00 USD
+157,7%
03/19/2026
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,82 млн
3,72 млн
4,65 млн
1,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,04 млн
4,20 млн
4,02 млн
5,22 млн
Operating expense
9,87 млн
7,62 млн
8,67 млн
6,91 млн
Total operating expenses
9,87 млн
7,62 млн
8,67 млн
6,91 млн
Operating income
-9,87 млн
-7,62 млн
-8,67 млн
-6,91 млн
Other non operating income
496,00 миң
-6,00 миң
17,00 миң
6,00 миң
EBT including unusual items
-7,02 млн
-7,35 млн
-6,72 млн
-7,00 млн
EBT excluding unusual items
-7,02 млн
-7,35 млн
-6,72 млн
-7,00 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-300,00 миң
-
-
Net income
-7,02 млн
-7,35 млн
-6,72 млн
-7,00 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
504,00 миң
421,00 миң
327,00 миң
278,00 миң
Interest expense
-28,00 миң
-23,00 миң
-20,00 миң
-16,00 миң
Net interest expenses
476,00 миң
398,00 миң
307,00 миң
262,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,82 млн
-7,16 млн
-8,50 млн
-6,75 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору